← All indications
Thyroid Diseases
Pathological processes involving the THYROID GLAND.
Subtype terms (8)
More specific conditions that are subtypes of Thyroid Diseases in the MeSH hierarchy.
- Euthyroid Sick Syndromes
4 drugs approved
- Goiter
9 drugs (7 approved, 2 experimental)
- Hyperthyroidism
25 drugs (16 approved, 9 experimental)
- Hyperthyroxinemia
- Hypothyroidism
45 drugs (32 approved, 13 experimental)
- Thyroid Dysgenesis
- Thyroiditis
- Thyroid Neoplasms
270 drugs (155 approved, 115 experimental)
Drugs by status
Approved for this indication (3)
Phase 4 trials (13)
Phase 3 trials (5)
Phase 2 trials (7)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (35)
- Eisai
- Exelixis
- Genzyme
- Sanofi
- Horizon Therapeutics, LLC
- Shenzhen SiBiono GeneTech Co.,Ltd
- National Cancer Institute, France
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- First Affiliated Hospital of Chongqing Medical University
- Centre Hospitalier Universitaire de Pointe-a-Pitre
- Doctors Hospital at Renaissance
- Shandong Provincial Hospital
- Stanford University
- Sichuan University
- University of Lausanne
- University of Southern Denmark
- University of Toronto
- University of Bern
- Yonsei University
- Chongqing Medical University
- Kavaklıdere Umut Hospital
- Dalian Medical University
- University of California, Los Angeles
- University of Copenhagen
- University of Ankara
- Shandong Province Qianfoshan Hospital
- Saint-Petersburg State Medical University
- University of Wisconsin
- Akrimax Pharmaceuticals
- Government of Brazil
- +5 more
Organization Involved with Phase 3 Indications (30)
- Horizon Pharma
- Amgen
- AstraZeneca
- Eli Lilly
- Bayer
- Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
- Mateon Therapeutics
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- National Cancer Center, Korea
- University of Pennsylvania
- Cedars-Sinai Medical Center
- Cancer Research UK
- University of London
- Cornell University
- Lund University
- Newcastle University
- University of Milan
- Yale University
- Tel Aviv University
- Tsinghua University
- University of Vienna
- Loxo Oncology
- University of Santiago
- Isfahan University
- Institut Gustave Roussy
- Centro Oftalmológico Moreiras
- Cantonal Hospital of St. Gallen
- University of Nantes
- Johannes Gutenburg University
- Chinese Academy of Medical Sciences
Organization Involved with Phase 2 Indications (79)
- Regeneron
- Daiichi Sankyo
- Celgene
- Millennium Pharmaceuticals
- Bristol-Myers Squibb
- Immunomedics
- Merck
- Genentech
- Pfizer
- Ipsen
- Novartis
- Allergan
- GlaxoSmithKline
- Neothetics, Inc
- River Vision Development Corporation
- Salient Pharmaceuticals Incorporated
- Eanm Research Ltd
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- Region Skane
- Academic and Community Cancer Research United
- Case Western Reserve University
- Centre Leon Berard
- Harvard University
- ECOG-ACRIN Cancer Research Group
- Emory University
- Georgetown University
- University of Washington
- Grupo Espanol de Tumores Neuroendocrinos (GETNE)
- Institut National de la Santé Et de la Recherche Médicale, France
- +49 more
Organization Involved with Phase 1 Indications (26)
- Blueprint Medicines Corporation
- Celldex Therapeutics
- Medical University Innsbruck
- The New York Eye & Ear Infirmary
- University of Groningen
- University of Pisa
- Utrecht University
- University of Zurich
- Assiut University
- University of Colorado, Denver
- Vanderbilt University
- University of Basel
- University of Freiburg
- University of Missouri
- University of Ljubljana
- State University of New York, Buffalo
- Jagiellonian University
- Erasmus University Rotterdam
- American Cancer Society, Inc.
- Krebsforschung Schweiz, Bern, Switzerland
- Alberta Cancer Foundation
- Yeshiva University
- NATIONAL CENTRE FOR NUCLEAR RESEARCH, Poland
- INRASTES, NCSR Demokritos, Athens, Greece
- Paul Scherrer Institute, Villigen, Switzerland
- AffyImmune Therapeutics, Inc.
Organization Involved with Other Experimental Indications (44)
- United States Army
- Bakirkoy Dr. Sadi Konuk Research and Training Hospital
- Chulalongkorn University
- Deutsche Krebshilfe e.V.
- Hellenic Red Cross Hospital
- Inje University
- Ito Hospital
- Julius-Maximilians University
- Kaohsiung Medical University
- Mahidol University
- Radboud University
- Seoul National University
- Siriraj Hospital
- Southwest Oncology Group
- Tufts University
- University of Tartu
- University of Valencia
- Zagazig University
- Istanbul University
- University of California, Irvine
- Federal University of Rio de Janeiro
- Jiao Tong University
- Emek Medical Center
- Southern Medical University
- Ospedale Vito Fazzi
- National Taiwan University
- International Thyroid Eye Disease Society
- Technion University
- Magna Graecia University
- University of Gothenburg
- +14 more